BridgeMD
New treatment option for Type 2 Diabetes Mellitus (T2DM)
Official title Diabetes Management Using Continuous Glucose Monitors and Remote Patient Monitoring in Underserved Populations
ClinicalTrials.gov ID: NCT06939413
What this study is testing
- What it's testing
- The goal of this 52 week prospective study is to learn whether a Diabetes Care Management Program using a continuous glucose monitor (CGM) and remotely monitoring (RPM) glucose readings can help improve glucose levels and diabetes related distress in individuals with uncontrolled type 2 diabetes. The CGM and RPM are used as an adjunct to usual care.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Adults 18 years or older with Type 2 diabetes AND
- A1c \> 8%
You likely can't join if
- Pregnancy (participant-reported)
- Previous real time CGM use for more than 6 weeks in the last 3 months
- Use of steroids
- Active cancer treatment
- Terminal illness
- Dementia, mental impairment
See the full eligibility criteria
- Adults 18 years or older with Type 2 diabetes AND
- A1c \> 8%
- Pregnancy (participant-reported)
- Previous real time CGM use for more than 6 weeks in the last 3 months
- Use of steroids
- Active cancer treatment
- Terminal illness
- Dementia, mental impairment
- Type 1 diabetes
- End stage renal disease, on dialysis
The study team makes the final eligibility decision.
Where it's taking place
- Greenfield, Massachusetts, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Greenfield, Massachusetts, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.